Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

Labcorp Holdings Inc. (LH) PE Ratio: 23.57

Is Labcorp Holdings Inc.’s P/E ratio high or low?

Labcorp Holdings Inc.'s P/E ratio of 23.57 is in line with its 5-year average of 23.40, around the middle of its 5-year range (7.97–48.65).

As of Sunday, June 14, 2026. 13.33% below its 12-month average of 27.20.

PE Ratio (23.57) = Close Price ($266.16) / Diluted TTM EPS ($11.29)

LH PE Ratio Chart

LH PE Ratio
23.57-21.90% 1Y
Zoom

LH Average PE Ratio Chart

LH Current vs Average PE Ratio Chart

LH PE Ratio Metrics

PE RATIO

23.57

PE RATIO AVG TTM

27.20

PE RATIO AVG 3Y

32.15

PE RATIO AVG 5Y

23.40

PE RATIO AVG 10Y

21.23

PE RATIO AVG 15Y

19.49

PE RATIO AVG 20Y

18.44

CURRENT VS TTM AVG

-13.33%

CURRENT VS 3Y AVG

-26.68%

CURRENT VS 5Y AVG

+0.74%

CURRENT VS 10Y AVG

+11.04%

CURRENT VS 15Y AVG

+20.96%

CURRENT VS 20Y AVG

+27.82%

LH Competitors' PE Ratio

NAMEMARKET CAPPE RATIOTTM3Y5Y
Labcorp Holdings Inc. (LH)$21.83B23.5727.2032.1523.40
Mettler-Toledo International Inc. (MTD)$22.86B26.4931.9732.7836.41
BioNTech SE (BNTX)$22.90BN/A55.7322.6282.47
United Therapeutics Corporation (UTHR)$23.17B20.1817.0714.9416.04
Waters Corporation (WAT)$23.17B45.1832.0230.9630.45
Moderna, Inc. (MRNA)$19.80BN/A15.4632.5132.51
Veeva Systems Inc. (VEEV)$25.92B28.4446.8454.5866.72
Hologic, Inc. (HOLX)$16.97B31.6728.1230.0822.83
DexCom, Inc. (DXCM)$29.08B32.2141.7671.44113.43
Biogen Inc. (BIIB)$29.53B21.4216.5918.5018.66

P/E vs. its own history

At 23.6, P/E is richer than usual, sitting higher than 84% of its 20-year history.

20-year low

7.5

median

15.7

20-year high

53.4

cheaperricher

P/E Comparison

Trailing P/E

23.6

Forward P/E

13.7

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$266.16

÷

Forward EPS (Est.)

$19.49

=

Forward P/E

13.65

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

Labcorp Holdings Inc. PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Labcorp Holdings Inc. PE Ratio FAQ

What is the P/E ratio for Labcorp Holdings Inc. (LH)?
The P/E ratio for LH stock is 23.57.
Is Labcorp Holdings Inc.'s P/E ratio high or low?
Labcorp Holdings Inc.'s P/E ratio of 23.57 is in line with its 5-year average of 23.40, around the middle of its 5-year range (7.97–48.65).
What is the TTM average P/E ratio for Labcorp Holdings Inc. (LH)?
The TTM average P/E ratio for LH stock is 27.20.
What is the 3Y average P/E ratio for Labcorp Holdings Inc. (LH)?
The 3Y average P/E ratio for LH stock is 32.15.
What is the 5Y average P/E ratio for Labcorp Holdings Inc. (LH)?
The 5Y average P/E ratio for LH stock is 23.40.
What is the 10Y average P/E ratio for Labcorp Holdings Inc. (LH)?
The 10Y average P/E ratio for LH stock is 21.23.
What is the 15Y average P/E ratio for Labcorp Holdings Inc. (LH)?
The 15Y average P/E ratio for LH stock is 19.49.
What is the 20Y average P/E ratio for Labcorp Holdings Inc. (LH)?
The 20Y average P/E ratio for LH stock is 18.44.

Labcorp Holdings Inc. PE Ratio History

DATEPE RATIO
2026-06-1223.57
2026-06-1123.50
2026-06-1023.79
2026-06-0924.02
2026-06-0823.21
2026-06-0523.49
2026-06-0423.12
2026-06-0322.93
2026-06-0222.83
2026-06-0122.75
2026-05-2923.03
2026-05-2823.27
2026-05-2722.87
2026-05-2622.89
2026-05-2223.02
2026-05-2122.65
2026-05-2022.80
2026-05-1922.47
2026-05-1822.64
2026-05-1522.18
2026-05-1422.50
2026-05-1322.53
2026-05-1222.79
2026-05-1122.59
2026-05-0822.51
2026-05-0722.86
2026-05-0622.76
2026-05-0522.78
2026-05-0422.41
2026-05-0124.46
2026-04-3024.55
2026-04-2924.58
2026-04-2824.82
2026-04-2725.18
2026-04-2425.22
2026-04-2325.33
2026-04-2226.06
2026-04-2126.14
2026-04-2025.74
2026-04-1725.88
2026-04-1625.46
2026-04-1525.50
2026-04-1425.70
2026-04-1325.26
2026-04-1024.95
2026-04-0926.12
2026-04-0826.26
2026-04-0725.73
2026-04-0626.24
2026-04-0226.17
2026-04-0126.07
2026-03-3125.51
2026-03-3025.20
2026-03-2725.26
2026-03-2625.66
2026-03-2525.43
2026-03-2425.44
2026-03-2325.28
2026-03-2025.14
2026-03-1925.25
2026-03-1825.41
2026-03-1725.87
2026-03-1625.51
2026-03-1325.22
2026-03-1225.13
2026-03-1125.85
2026-03-1025.69
2026-03-0926.16
2026-03-0625.78
2026-03-0526.38
2026-03-0426.85
2026-03-0327.05
2026-03-0227.39
2026-02-2727.64
2026-02-2627.50
2026-02-2527.03
2026-02-2427.45
2026-02-2328.03
2026-02-2027.77
2026-02-1927.75
2026-02-1827.38
2026-02-1727.18
2026-02-1327.76
2026-02-1227.32
2026-02-1128.48
2026-02-1027.95
2026-02-0926.92
2026-02-0627.23
2026-02-0527.33
2026-02-0427.13
2026-02-0326.74
2026-02-0226.55
2026-01-3026.67
2026-01-2926.50
2026-01-2826.33
2026-01-2726.63
2026-01-2626.27
2026-01-2326.19
2026-01-2226.52
2026-01-2126.44
2026-01-2026.65
2026-01-1626.61
2026-01-1526.41
2026-01-1425.74
2026-01-1324.95
2026-01-1224.60
2026-01-0924.74
2026-01-0825.02
2026-01-0724.92
2026-01-0625.58
2026-01-0524.87
2026-01-0224.72
2025-12-3124.64
2025-12-3024.86
2025-12-2924.85
2025-12-2624.94
2025-12-2425.00
2025-12-2324.87
2025-12-2225.06
2025-12-1924.76
2025-12-1824.76
2025-12-1725.13
2025-12-1625.35
2025-12-1525.87
2025-12-1225.95
2025-12-1126.00
2025-12-1025.74
2025-12-0925.35
2025-12-0825.53
2025-12-0525.38
2025-12-0425.69
2025-12-0326.11
2025-12-0226.12
2025-12-0126.30
2025-11-2826.40
2025-11-2626.35
2025-11-2526.51
2025-11-2426.06
2025-11-2126.09
2025-11-2025.68
2025-11-1925.59
2025-11-1825.52
2025-11-1725.67
2025-11-1426.22
2025-11-1326.31
2025-11-1226.13
2025-11-1126.35
2025-11-1025.65
2025-11-0724.83
2025-11-0624.23
2025-11-0524.63
2025-11-0424.79
2025-11-0325.33
2025-10-3124.95
2025-10-3027.82
2025-10-2927.36
2025-10-2828.63
2025-10-2730.39
2025-10-2430.81
2025-10-2331.31
2025-10-2231.18
2025-10-2131.33
2025-10-2032.08
2025-10-1731.53
2025-10-1631.28
2025-10-1531.17
2025-10-1430.85
2025-10-1330.50
2025-10-1030.64
2025-10-0930.63
2025-10-0830.60
2025-10-0730.83
2025-10-0630.33
2025-10-0330.53
2025-10-0230.81
2025-10-0130.77
2025-09-3031.65
2025-09-2931.17
2025-09-2630.94
2025-09-2530.45
2025-09-2430.80
2025-09-2330.86
2025-09-2230.75
2025-09-1930.57
2025-09-1830.56
2025-09-1730.44
2025-09-1630.22
2025-09-1530.36
2025-09-1230.64
2025-09-1130.84
2025-09-1030.09
2025-09-0930.66
2025-09-0830.56
2025-09-0530.72
2025-09-0430.35
2025-09-0330.19
2025-09-0230.19
2025-08-2930.65
2025-08-2830.35
2025-08-2730.79
2025-08-2630.70
2025-08-2530.44
2025-08-2230.67
2025-08-2130.49
2025-08-2030.66
2025-08-1930.40
2025-08-1829.82
2025-08-1529.81
2025-08-1429.91
2025-08-1330.05
2025-08-1229.69
2025-08-1129.51
2025-08-0829.31
2025-08-0728.66
2025-08-0628.76
2025-08-0529.05
2025-08-0429.09
2025-08-0128.83
2025-07-3130.00
2025-07-3030.44
2025-07-2930.19
2025-07-2830.21
2025-07-2530.56
2025-07-2430.88
2025-07-2328.89
2025-07-2229.07
2025-07-2128.03
2025-07-1828.11
2025-07-1728.52
2025-07-1628.37
2025-07-1528.33
2025-07-1428.81
2025-07-1128.79
2025-07-1029.25
2025-07-0929.88
2025-07-0829.69
2025-07-0729.74
2025-07-0330.21
2025-07-0229.99
2025-07-0130.48
2025-06-3030.28
2025-06-2730.06
2025-06-2629.64
2025-06-2529.84
2025-06-2430.28
2025-06-2330.11
2025-06-2030.21
2025-06-1830.15
2025-06-1729.93
2025-06-1630.45
2025-06-1330.12
2025-06-1230.18
2025-06-1129.98
2025-06-1029.92
2025-06-0929.50
2025-06-0629.29
2025-06-0529.08
2025-06-0429.34
2025-06-0328.89
2025-06-0228.59

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter